Abstract |
Oral tablets containing 375 mg sultamicillin were used to treat 30 adult patients of either sex suffering from lower respiratory tract infections. The dose used was one tablet every 12 h for 22 cases and one tablet every 8 h for eight cases. The duration of therapy varied between 5 and 14 days (mean 8.6 days). The therapeutic response was rated as cure in 23 (76.6%) patients, with complete disappearance of pretreatment signs and symptoms, and as improvement in seven (23.3%) patients, with amelioration of the pretreatment manifestations. All 52 microorganisms isolated before treatment were eradicated. No adverse effects were reported in 25 (83.3%) patients, whereas the remaining five (16.7%) patients reported mild loose stools with normal bowel motion. There were no abnormal changes in blood count and liver and renal functions following sultamicillin treatment.
|
Authors | M A Tageldin, A Said |
Journal | The Journal of international medical research
(J Int Med Res)
Vol. 20 Suppl 1
Pg. 44A-52A
( 1992)
ISSN: 0300-0605 [Print] England |
PMID | 1451929
(Publication Type: Journal Article)
|
Chemical References |
- Tablets
- sultamicillin
- Ampicillin
- Sulbactam
|
Topics |
- Acute Disease
- Administration, Oral
- Adult
- Ampicillin
(therapeutic use)
- Bacterial Infections
(drug therapy)
- Bronchitis
(drug therapy)
- Chronic Disease
- Drug Therapy, Combination
(therapeutic use)
- Female
- Humans
- Male
- Pneumonia
(drug therapy)
- Respiratory Tract Infections
(drug therapy)
- Sulbactam
(therapeutic use)
- Tablets
|